Found 10 matching trials
ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer PHASE2 Some cancers may be related to an infection with a virus, such as the Human...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ PHASE2 Cervical cancer is associated with Human Papilloma Virus. About 57% of cerv...
Show More Location
New Horizons Women's Care, LLC
Learn More & Join Trial
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer PHASE1 The main purpose of this study is to study the safety and effectiveness of ...
Show More Location
Montefiore Medical Center
Learn More & Join Trial
Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer PHASE3 Locally advanced cervical cancer at higher risk for recurrence (HRLACC) fol...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer PHASE1 It is the investigators intention to investigate whether a specially design...
Show More Location
Velindre NHS Trust
Learn More & Join Trial
A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy PHASE2 * Open label
* Enrollment in the order of confirmation of eligibility and H...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal PHASE2 This is a single arm Phase 2 study. Stage 1 and 2 of the study are monother...
Show More Location
Multiple Locations
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2 This phase II trial studies the side effects and how well vaccine therapy w...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer PHASE1 To evaluate the tolerability and safety of axalimogene filolisbac 1 x 10\^1...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer PHASE1 This was a multicenter, open-label, 2-part randomized study of MEDI4736 adm...
Show More Learn More & Join Trial